Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Merrick

Showing results (71-80 of 261) with videos related to

Pageof 27
Sort By:
World Journal of Urology|December 1, 2016
Incidence, grade and distribution of prostate cancer following transperineal template-guided mapping biopsy in patients with atypical small acinar proliferationGregory S Merrick, Robert W Galbreath, Abbey Bennett, et al.
International Journal of Cancer|October 3, 2001
Short-term sexual function after prostate brachytherapyG S Merrick, K Wallner, W M Butler, et al.
AIDS (London, England)|January 12, 2000
Hepatitis C in an urban population infected with the human immunodeficiency virusD M Weinstock, S Merrick, S A Malak, et al.
Brachytherapy|October 23, 2015
Treatment outcomes with permanent brachytherapy in high-risk prostate cancer patients stratified into prognostic categoriesN Bittner, G S Merrick, R W Galbreath, et al.
Journal of Contemporary Brachytherapy|September 28, 2017
Prostate cancer-specific death in brachytherapy treated high-risk patients stratified by pre-treatment PSAGregory S Merrick, Robert W Galbreath, Wayne M Butler, et al.
Cancer Journal (Sudbury, Mass.)|August 3, 2004
Treatment margins predict biochemical outcomes after prostate brachytherapySeungtaek Choi, Kent E Wallner, Gregory S Merrick, et al.
American Journal of Clinical Oncology|December 4, 2004
Permanent interstitial brachytherapy for clinically organ-confined high-grade prostate cancer with a pretreatment PSA < 20 ng/mLGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Brachytherapy|April 6, 2004
Biochemical outcome for hormone-naïve intermediate-risk prostate cancer managed with permanent interstitial brachytherapy and supplemental external beam radiationGregory S Merrick, Wayne M Butler, Jonathan H Lief, et al.
Brachytherapy|November 4, 2015
Is supplemental external beam radiation therapy essential to maximize brachytherapy outcomes in patients with unfavorable intermediate-risk disease?Gregory S Merrick, Kent E Wallner, Robert W Galbreath, et al.
Cancer Journal (Sudbury, Mass.)|November 6, 2001
Perineural invasion is not predictive of biochemical outcome following prostate brachytherapyG S Merrick, W M Butler, R W Galbreath, et al.
Pageof 27

Showing results (71-80 of 261) with videos related to

Sort By:
Pageof 27
World Journal of Urology|December 1, 2016
Incidence, grade and distribution of prostate cancer following transperineal template-guided mapping biopsy in patients with atypical small acinar proliferationGregory S Merrick, Robert W Galbreath, Abbey Bennett, et al.
International Journal of Cancer|October 3, 2001
Short-term sexual function after prostate brachytherapyG S Merrick, K Wallner, W M Butler, et al.
AIDS (London, England)|January 12, 2000
Hepatitis C in an urban population infected with the human immunodeficiency virusD M Weinstock, S Merrick, S A Malak, et al.
Brachytherapy|October 23, 2015
Treatment outcomes with permanent brachytherapy in high-risk prostate cancer patients stratified into prognostic categoriesN Bittner, G S Merrick, R W Galbreath, et al.
Journal of Contemporary Brachytherapy|September 28, 2017
Prostate cancer-specific death in brachytherapy treated high-risk patients stratified by pre-treatment PSAGregory S Merrick, Robert W Galbreath, Wayne M Butler, et al.
Cancer Journal (Sudbury, Mass.)|August 3, 2004
Treatment margins predict biochemical outcomes after prostate brachytherapySeungtaek Choi, Kent E Wallner, Gregory S Merrick, et al.
American Journal of Clinical Oncology|December 4, 2004
Permanent interstitial brachytherapy for clinically organ-confined high-grade prostate cancer with a pretreatment PSA < 20 ng/mLGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Brachytherapy|April 6, 2004
Biochemical outcome for hormone-naïve intermediate-risk prostate cancer managed with permanent interstitial brachytherapy and supplemental external beam radiationGregory S Merrick, Wayne M Butler, Jonathan H Lief, et al.
Brachytherapy|November 4, 2015
Is supplemental external beam radiation therapy essential to maximize brachytherapy outcomes in patients with unfavorable intermediate-risk disease?Gregory S Merrick, Kent E Wallner, Robert W Galbreath, et al.
Cancer Journal (Sudbury, Mass.)|November 6, 2001
Perineural invasion is not predictive of biochemical outcome following prostate brachytherapyG S Merrick, W M Butler, R W Galbreath, et al.
Pageof 27